What does RevolKa Ltd. do?
RevolKa Ltd is a biotechnology company based in Sendai, Japan that offers an AI-driven protein engineering platform called aiProtein. The platform leverages advanced AI techniques to design proteins with specific functions for pharmaceutical and industrial applications.
How much did they raise?
The company raised US$1.4M in a Series A Extension round. The funding was co-led by D3 LLC and TOHOKU University Venture Partners Co., Ltd., with participation from DEEPCORE Inc.
What are their plans for the money?
RevolKa Ltd plans to use the funds to advance its drug discovery programs targeting rare diseases and to support collaborative partnering efforts, potentially accelerating the development of new therapeutics.
What have they achieved so far?
The company has already made strides with its proprietary aiProtein platform, which is designed to efficiently generate protein sequences with desired functions by training on sequence-to-function relationship data.
